Document is current
Any future updates will be listed below
-
Authors
Yearley, Alexander G.
Chalif, Eric J.
Gupta, Saksham
Chalif, Joshua I.
Bernstock, Joshua D.
Nawabi, Noah
Arnaout, Omar
Smith, Timothy R.
Reardon, David A.
Laws, Edward R.
- License Information
-
More Information
Article History
Accepted: 7 July 2023
First Online: 31 July 2023
Declarations
:
: This study was approved by the Mass General Brigham Institutional Review Board (Protocol #2015P002352).
: JDB has an equity position in Treovir Inc., an oHSV clinical stage company and is a member of the POCKiT Diagnostics, Centile Bioscience and NeuroX1 Boards of Scientific Advisors.
